Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT07936188

Phase 2 Study of GC4006A in Healthy Adults

Conditions: Covid-19 Prevention

Sex: All
Ages: 19 Years – 85 Years
Healthy volunteers: Yes
Phase: PHASE2
Enrollment: 210
Sponsor: GC Biopharma Corp

Location: Korea University Guro Hospital Seoul Seoul

Summary

The purpose of this study is to evaluate the safety and immunogenicity of the COVID-19 preventive vaccine 'GC4006A' in healthy adults aged 19 to 85 years

Eligibility Criteria

Inclusion Criteria: * Age 19-85 with written informed consent * ≥16 weeks since last COVID-19 vaccination Exclusion Criteria: * Positive SARS-CoV-2 test (RT-PCR/Rapid Antigen) at screening or randomization * \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07936188). StuddyBuddy aggregates publicly available trial information.